Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

pembrolizumab 1270 Specimen Handling 870 Carboplatin 831 Magnetic Resonance Spectroscopy 808 Cyclophosphamide 802 Cisplatin 728 Nivolumab 658 Paclitaxel 631 Radiotherapy 573 Gemcitabine 572 Biopsy 529 Bevacizumab 475 Dexamethasone 440 fludarabine 407 Docetaxel 378 venetoclax 370 Oxaliplatin 365 Capecitabine 356 Fluorouracil 354 atezolizumab 341 durvalumab 334 Rituximab 332 Doxorubicin 316 Radiosurgery 309 Pemetrexed 305 Drug Therapy 302 Ipilimumab 294 Standard of Care 293 Etoposide 285 Radiation 279

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × molgramostim × 1 year × Clear all

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡